Ocuphire Pharma (OCUP) Financials

$1.01

$-0.12 (-10.62%)

As on 21-Nov-2024 09:30EDT

Market cap

$32 Mln

Revenue (TTM)

$16 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	16.45	19.05	39.85	0.59	0.10	--
Cost of Revenue	5.03	0.01	0.00	0.00	0.01	0.00
Gross Profit	11.42	19.04	39.85	0.59	-0.01	0.00
Operating Expenses	31.53	29.61	21.62	23.29	9.47	4.19
Operating Profit (EBIT)	-15.08	-10.56	18.23	-22.71	-19.97	-4.19
Other Income	--	--	--	--	--	--
Profit before Tax	-14.09	-9.97	18.20	-56.69	-24.62	-6.17
Provision for Tax	-0.02	0.01	0.32	-0.16	6.86	1.34
Profit after Tax (Net Income)	-14.11	-9.99	17.89	-56.53	-31.48	-7.51
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	17.89	-56.69	-24.62	-6.17

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	40.64	49.91	46.24	22.22	-13.47	-7.56
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	1.07	2.12	27.96	0.11
Current Liabilities	4.20	4.04	2.75	3.86	3.19	9.34
Total Liabilities	49.03	53.95	48.99	26.08	17.68	1.78

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	--	--	0.01	0.01	0.01	0.02
Current Assets	44.83	53.95	48.99	26.07	17.67	1.76
Total Assets	49.03	53.95	48.99	26.08	17.68	1.78
Total Debt*	--	--	--	0.54	--	5.67
Net Current Assets	40.64	49.91	46.23	22.21	14.48	-7.58

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-1.11	14.31	-19.37	-6.80	-3.59
Cash Flow from Investing Activities	--	--	--	-0.10	0.54	-0.03
Cash from Financing Activities	--	8.98	3.79	27.61	21.12	4.70
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-20.77	51.85	-1,216.70	409.84	-173.24
ROE (%)	-31.16	-20.77	52.26	-1,291.47	299.39	-500.18
ROA (%)	-28.71	-19.40	47.66	-258.39	-323.39	-84.25
EBIT Margin (%)	-87.84	-52.36	45.74	-9,624.96	-19,976.00	--
Net Margin (%)	-85.75	-52.42	44.89	-9,598.30	-31,476.00	--
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-63.67	-0.52	66.66	4.89	--	--
EBIT Growth (%)	-177.76	-154.72	132.15	-183.80	-376.41	79.58
Net Profit Growth (%)	-174.22	-155.83	131.64	-79.61	-319.12	47.73
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.93	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.55	5.07	-2.34	0.43	0.82	-0.27
Close Price ($)	1.53	3.01	3.53	3.73	6.49	7.64
High Price ($)	4.58	6.60	4.43	13.81	17.04	79.20
Low Price ($)	1.50	2.55	1.78	3.19	3.68	6.24
Market Cap ($ Cr)	31.74	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	--	--	0.02	--	-0.75
Short term debt to equity ratio	--	--	--	0.02	-0.42	-0.75
Current Ratio	10.68	13.35	17.79	6.76	5.55	0.19
Quick Ratio	10.68	--	17.79	--	--	0.18
Interest Coverage	--	--	2,025.11	-28,345.50	-2.92	-2.98

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	14.02	12.25	12.17	--	--	--
Asset Turnover	0.33	0.37	1.06	0.03	0.01	--
Receivable days	--	68.86	22.23	--	456.56	--
Inventory Days	--	0.06	0.09	--	4,337.34	11,566.25
Payable days	--	98,069.63	121,126.03	127,746.19	35,520.56	50,671.25
Cash Conversion Cycle	--	-98,000.70	-121,103.71	--	-30,726.66	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.